
The Diabetes Prevention Program is a zzso clinical trial testing strategies to prevent or delay the development of type 2 diabetes in high-risk individuals with elevated zzso plasma zzso zzso and impaired zzso zzso The 27 clinical centers in the zzso are recruiting at least 3,000 participants of both zzso approximately 50% of whom are minority patients and zzso of whom zzso or zzso 65 years old, to be assigned at random to one of three intervention groups: an intensive lifestyle intervention focusing on a healthy diet and exercise and two masked medication treatment zzso or zzso with standard diet and exercise zzso Participants are being recruited during a 2 zzso period, and all will be followed for an additional 3 1/3 to 5 years after the close of recruitment to a common closing date in zzso The primary outcome is the development of diabetes, diagnosed by zzso or zzso plasma zzso zzso meeting the 1997 American Diabetes Association zzso The 3,000 participants will provide zzso power to detect a zzso reduction in an expected diabetes zzso rate of at least zzso per year in the zzso zzso Secondary outcomes include cardiovascular disease and its risk zzso changes in zzso zzso function, insulin sensitivity, zzso diet, physical activity, and zzso quality of life; and occurrence of adverse zzso A fourth treatment zzso combined with standard diet and exercise zzso included initially but discontinued because of the liver toxicity of the zzso This zzso clinical trial will test the possibility of preventing or delaying the onset of type 2 diabetes in individuals at high zzso 

